Skip to main content

Table 2 Surgery and postoperative course

From: Palliative bypass surgery for patients with advanced pancreatic adenocarcinoma: experience from a tertiary center

 

n = 42

Laparoscopy/open (ratio)

22/20 (1.1)

GJ only, n (%)

31 (73.8)

Double bypass, n (%)

11 (26.1)

Overall surgery time, min (mean ± SD)

205 ± 78

Open gastro-jej time, min (mean ± SD)

225 ± 71

Lap gastro-jej time, min (mean ± SD)

162 ± 53

Double bypass surgery time, min (mean ± SD)

270 ± 76

Patients requiring blood units in op, n (%)

Postoperative complications, n (%)

 Clavien-dindo ≥ 3

15 (35.7)

 Leak of anastomosis

4 (9.5)

 Bleeding

4 (9.5)

 DVT

2 (4.76)

 Reoperation within 30 days

6 (14.2)

Return to oral intake during post-op, n (%)

34 (80.9)

Length of stay, days (mean ± SD, range)

18.3 ± 22.2, 2–108

30 days mortality, n (%)

7 (16.6)

60 days mortality, n (%)

14 (33.3)

Returning to chemotherapy, n (%)

18 (42.8)

Revisional palliative surgery, n (%)

3 (7.14)

Palliation failure

17 (40.5)

Overall survival (mean ± SD)

172.8 ± 179.2

Median survival

94.5

  1. DVT deep vein thrombosis, Lap laparoscopic, GJ gastrojejunostomy